Skin aging and most age-related diseases are associated with a low-grade chronic inflammation. The nucleoside adenosine, a potent endogenous antiinflammatory agent, is deeply involved in inflammatory diseases and, by interaction with the adenosine A 2 receptor (A 2A R) it immediately promotes a mechanism of defence against the inflammatory damage. The aim of our study was to investigate whether polydeoxyribonucleotide (PDRN), a mixture of deoxyribonucleotides polymers of different lengths that like adenosine, binds the A 2A receptor, can reduce the inflammatory state in the macrophage cell line. RAW264.7, murine macrophage cells, were incubated with PDRN in the presence and in the absence of lipopolysaccaride (LPS), which was the major component of the outer membrane of gram-negative bacteria and which acted as a strong macrophage activator. We assessed the production of nitric oxide and the secretion of inflammatory mediators (i.e., TNF-α, IL-10, IL-12 and VEGF-A). Our data showed that PDRN produced a significant decrease of inflammation in macrophages pre-stimulated with LPS, assessed in terms of the nitric oxide content (p < 0.001) and cytokines secretion (p < 0.001). Moreover, PDRN stimulated the release of the vascular endothelial growth factor (VEGF-A), which promoted wound healing. Our study suggested that PDRN, by binding the A 2A receptor, contributed to a great extent towards reducing inflammation.
Introduction
Aging is a multifactorial and progressive degenerative process defined as an accumulation of damage and is closely associated with inflammation. While the etiology of the aging process is not fully understood [1] , chronic inflammation How to cite this paper: Castellini, C., Belletti, S., Govoni, P. and Guizzardi, S. (2017) Anti Inflammatory Property of clearly plays a major role, inextricably linking inflammation and aging. Indeed, the levels of inflammatory mediators increase typically with age even in the absence of acute infection or other types of physiologic stress [2] .
Continuous up-regulation of pro-inflammatory mediators is induced during the aging process due to an age-related redox imbalance. It is likely that it is caused by the decisive effect of weakened anti-oxidative defence systems and the increased production of reactive oxygen species, such as hydrogen peroxide (H 2 O 2 ) and reactive nitric oxide (NO) [2] . This imbalance that results in the low grade chronic pro-inflammatory state, is referred as inflammaging [3] .
The process of skin aging is complex and results from a combination of intrinsic (or chronological) and extrinsic factors, i.e. UV radiation (or photoaging), cigarette smoking, air pollution and incorrect nutrition. Intrinsic aging is accompanied by cell loss, thinning of the dermis and fine lines. Inflammaged skin is wrinkled, is associated with dyspigmentation and shows proteolytic activation and degradation of collagen and elastic fibres in the dermis. Inflammation and the accumulation of Reactive Oxygen Species (ROS) are believed to be the main causes of skin aging [4] [5] .
It has been suggested that monocytes and macrophages contribute towards inflammaging more than any other cell type. Macrophages are heterogeneous and are present in most tissues where they are responsible for numerous inflammatory, immunological and metabolic processes [6] . Monocytes change with age and contribute to inflammaging by causing a functional shift towards a proinflammatory phenotype and reduced function [7] ; indeed these cells increase the production of inflammatory cytokines and the lengthen of the immune response [8] .
One of the major pathways by which the oxidative damage produced by free radicals promotes inflammatory responses, involves the Toll-like-receptors (TLRs). TLRs are a family of ubiquitously expressed receptors that play an important role in the innate immune response, particularly in the initial interaction between the infecting microorganism and phagocytic cells, such as macrophages [9] .
TLRs recognize molecules that are crucial for the integrity of the microorganism, but that are non-self molecules either due to their chemical composition or due to their cellular localisations [10] . Microbial cell-wall components such as lipopolysaccharides (LPSs), endotoxins from the outer membranes of gramnegative bacteria, lipopeptides and flagellar proteins are recognized at the plasma membrane of immune and epithelial cells by TLR4, TLR2 and TLR5, respectively [11] .
In particular, TLR4 activation by LPSs initiates an inflammatory response, whose key mediators are tumour necrosis factor-α (TNF-α) and interleukin-12 (IL-12), and secrete nitric oxide (NO), a short-lived free radical, which mediates many biological functions such as host defence, neurotransmission, neurotoxicity and vasodilation. In elderly persons, an increased level of these pro-inflammatory cytokines is often observed both in the general circulation and in tis-sue-resident macrophages [12] .
In addition to the resolution of inflammation in response to pathogens or tissue damage, macrophages are also involved in the promotion of proper wound healing, by inducing the production of VEGF and angiogenesis. These specific physiological functions derive from the plasticity of macrophages that allow them to change their form and function in response to environmental signals.
Current macrophage classification recognizes polarization according to two distinct phenotypes: classically (M1) or alternatively (M2) activated macrophages [13] .
M1 macrophages are activated by pathogen-associated molecular patterns, such as LPS or by the T cell-secreted cytokine interferon gamma (IFNγ). They are of the pro-inflammatory phenotype, increasing the production of proinflammatory cytokines (e.g., IL-1, IL-6, IL-12 and TNF-α) and oxidative metabolites (e.g., NO and superoxide) to promote host defence.
M2 macrophages, on the other hand, are induced by a variety of stimuli (e.g., IL-4/IL-13 and glucocorticoids) and are of a phenotype involved in the promotion of wound healing, tissue remodelling and the resolution of inflammation [13] . The nucleoside adenosine is an endogenous anti-inflammatory agent and is a potent physiologic and pharmacologic regulator that is produced by cells in response to stress due to the breakdown of ATP. In particular, activation of the A 2A receptor is one of the most fundamental and immediate mechanisms for protecting tissues against inflammatory damage, altering the cytokines network by decreasing the secretion of inflammatory cytokines by macrophages in vitro [16] .
Several studies have indicated that adenosine is involved in the modulation of the inflammatory process [17] , e.g. A 2A R agonists inhibit cartilage damage, by diminishing IL-8 expression [18] or reduce the inflammatory response in articular chondrocytes [19] .
Polydeoxyribonucleotide (PDRN) is a mixture of deoxyribonucleotides polymers of different lengths and is an A 2A receptor agonist. PDRN is commonly used in clinical settings for pre and post-surgical cutaneous treatments, diabetic foot ulcers and venous ulcers because it stimulates fibroblast metabolism and promotes an increase in dermal matrix component production [20] . Other clinical studies have also pointed out that PDRN promotes faster healing of autologous skin grafts at donor sites [21] [22] .
The aim of this work was to investigate whether polydeoxyribonucleotide (PDRN), an A 2A receptor agonist, can induce an anti-inflammatory phenotype in murine macrophage cells RAW264.7, endowed with high endogenous TLR4 expression, focusing on nitric oxide production and secretion of inflammatory mediators.
Materials and Methods

PDRN
Polydeoxyribonucleotide (PDRN, Mastelli srl, Sanremo, Italy) is a DNA fraction containing a mixture of deoxyribonucleotide polymers of different lengths, comprised between 50 and 2000 base pairs. It was obtained from fish for human consumption by using Mastelli's peculiar methods, by means of purification and high-temperature sterilization procedures that ensure a very high percentage of purified DNA and the absence of active proteins and peptides [23] .
Cell Culture and Experimental Treatments
Murine peritoneal monocyte-macrophage cells (RAW264.7 line) were obtained from the Cell Bank of the Istituto Zooprofilattico della Lombardia e dell'Emilia Romagna (Brescia, Italy). The cells were routinely grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% Foetal Bovine Serum (FBS), 4 mM glutamine and antibiotics (streptomycin, 100 µg•ml −1 ; penicillin, 100 U•ml −1 ) and kept in a humidified atmosphere of 5% CO 2 at 37˚C. , A 2A receptor agonists significantly suppressed LPS-induced inflammation [16] . Depending on the experimental setting, PDRN was added immediately (0 h) or after 1 h, 2 h or 3 h after the exposure to LPS and kept throughout the experiments.
Cell Viability
Cell viability was assessed with the resazurin method [24] . Resazurin is a nonfluorescent molecule which is converted by intracellular enzymes into the fluorescent compound resorufin (λ em = 572 nm). After 24 h of incubation, cell viability was tested replacing the medium with a solution of resazurin (44 μM, Sigma Aldrich) in serum-free DMEM. After 20 min, fluorescence was measured at 572 nm with a multi-plate reader.
Determination of NO Production
Nitrite concentration in the culture media, as an indicator of NO production, was determined 24 h after treatments with PDRN by means of a fluorimetric approach, based on the production of the fluorescent molecule 1H-naphthotriazole from 2,3-diaminonaphthalene (DAN) in an acid environment [25] . 100 μl of medium were transferred to black 96-well plates with a clear bottom 
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Materials
Unless otherwise stated, all the reagents were provided by Sigma Aldrich, Milan, Italy.
Statistical Analysis
The results are expressed as means ± standard deviation (mean ± SD). Statistical analyses were performed using GraphPad Prism® software version 5.00 (GraphPad Software Inc., San Diego, CA). The data were compared using one-way ANOVA tests and checked with Bonferroni's post hoc tests. Results were considered significant at p < 0.05 compared to cells treated with LPS (positive control).
Results
Cell Viability
The effects of PDRN, alone or in combination with LPS (1 -10 ng•ml −1 ), on the viability of RAW264.7 cells were tested using the resazurin assay after exposure for 24 h. PDRN, both alone and with LPS (1 -10 ng•ml −1 ), did not significantly reduce cell viability, as shown in Figure 1 . 
Nitric Oxide Production
Secretion of Pro-and Anti-Inflammatory Cytokines
The secretion of the pro-inflammatory cytokines TNF-α, IL-12 and anti-inflammatory cytokine IL-10 was quantified after the treatment of RAW264. TNF-α and IL-10 were determined 6 h after treatments while the production of IL-12 was assessed after 24 h after treatments with LPS and PDRN.
As shown in Figure 3 , the exposure to PDRN added after 2 h of stimulation with LPS produced a significant and marked decrease both of TNF-α and of IL-12, by 47% and 16% respectively (p < 0.001).
Our results showing that PDRN inhibit TNF-α and IL-12 production suggest that the beneficial effects of PDRN in inflammatory processes or injury may be attributed partly to this inhibition.
Moreover, PDRN produced a pronounced increase of IL-10 compared with stimulation with LPS (2-fold induction).
Anti-inflammatory properties of IL-10 are well documented and include the control of TNF-α release in vitro and in vivo [26] . The present study showed that PDRN is able to increase IL-10 production after stimulation with LPS and this phenomenon contributed to TNF-α inhibition.
Secretion of VEGF-A
The effects of PDRN on VEGF-A production by RAW264.7 cells was evaluated 24 h after treatment with LPS (10 ng•ml ), added either simultaneously or 2 h after stimulation with LPS. As shown in Figure 4 , PDRN markedly increases the secretion of VEGF-A by 42%.
Discussion
Age-associated low grade inflammation (inflammaging) is now recognized to be the driving force of many age-associated diseases [27] . ). After 24 h of treatment, VEGF-A was measured in the extracellular medium, as described under Materials and Methods. The results are expressed as the means of three independent determinations ± S.D. ***p < 0.001 vs. positive control, cells treated with LPS.
As we age, the innate immune system becomes dysregulated and is characterized by persistent inflammatory responses that involve multiple immune and non-immune cell types. This dysregulation involves both elevated levels of basal inflammation and an associated impaired ability to mount efficient innate and adaptive immune responses [28] .
It has recently been established that inflammation and innate immunity play roles in skin aging process. The immune system protects the skin from infection, removes damaged cells and prevents undesirable autoimmune reactions; it may, however, promote the aging process, due to intrinsic (or chronological) and extrinsic factors, such as exposure to the sun, air pollution, cigarette smoking, bad nutrition and through the generation of Reactive Oxygen Species (ROS) generation released by macrophages [29] .
Not only inflammatory states, but also ischaemia and tissue injury are pathological conditions in which intracellular ATP metabolism is accelerated, leading to the accumulation of intracellular adenosine.
Adenosine is a purine nucleoside that is released in response to metabolic stress and is a potent endogenous regulator, acting via four cell surface receptor subtypes (A 1 , A 2A , A 2B and A 3 ).
In particular, adenosine A 2A receptors are present in the monocyte-macrophage cell line [30] and, as a result of interaction with adenosine or agonists, these agents have been shown to be able to modulate macrophage functions, such as nitric oxide (NO) production, and to regulate cytokine production both in vitro and in vivo [16] [31] .
In this paper, we study the effects of polydeoxyribonucleotide (PDRN), an adenosine A 2 receptor (A 2A R) agonist, on RAW264.7, a murine macrophage cell line.
Our results showed that PDRN did not affect cell viability or cause a decrease in nitric oxide production when added to a macrophages pre-stimulated with relatively high doses of LPS (10 ng•ml −1 ). Our data suggest that in an on-going state of inflammation PDRN has as anti-inflammatory effect.
Our results were consistent with other studies [26] 
Conclusion
To conclude, PDRN may constitute a new, active and safe anti-inflammaging treatment, acting as an anti-inflammatory agent that can avoid or heal damage to the cellular and extracellular components.
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